Patterson KC, Chen ES (2018) The pathogenesis of pulmonary sarcoidosis and implications for treatment. Chest. https://doi.org/10.1016/j.chest.2017.11.030

Article  PubMed  Google Scholar 

Valeyre D, Prasse A, Nunes H et al (2014) Sarcoidosis. The Lancet 383:1155–1167. https://doi.org/10.1016/S0140-6736(13)60680-7

Article  Google Scholar 

Baughman RP, Valeyre D, Korsten P et al (2021) ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J 58:2004079. https://doi.org/10.1183/13993003.04079-2020

Article  CAS  PubMed  Google Scholar 

Kahlmann V, Janssen Bonás M, Moor CC et al (2020) Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study. BMC Pulm Med 20:271. https://doi.org/10.1186/s12890-020-01290-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vis R, Mathijssen H, Keijsers RGM et al (2023) Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis. J Nucl Cardiol. https://doi.org/10.1007/s12350-022-03171-6

Article  PubMed  Google Scholar 

Castaldo P, Magi S, Nasti AA et al (2011) Clinical pharmacogenetics of methotrexate. Curr Drug Metab 12:278–286. https://doi.org/10.2174/138920011795101840

Article  CAS  PubMed  Google Scholar 

Krajinovic M, Moghrabi A (2004) Pharmacogenetics of methotrexate. Pharmacogenomics 5:819–834. https://doi.org/10.1517/14622416.5.7.819

Article  CAS  PubMed  Google Scholar 

Rots MG, Pieters R, Peters GJ et al (1999) Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. Blood 93:1677–1683

Article  CAS  PubMed  Google Scholar 

Humbert M, Kovacs G, Hoeper MM et al (2023) 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 61:2200879. https://doi.org/10.1183/13993003.00879-2022

Article  PubMed  Google Scholar 

Vorselaars ADM, Wuyts WA, Vorselaars VMM et al (2013) Methotrexate vs azathioprine in second-line therapy of sarcoidosis. Chest 144:805–812. https://doi.org/10.1378/chest.12-1728

Article  CAS  PubMed  Google Scholar 

Tishler M, Caspi D, Graff E et al (1989) Synovial and serum levels of methotrexate during methotrexate therapy of rheumatoid arthritis. Br J Rheumatol 28:422–423. https://doi.org/10.1093/rheumatology/28.5.422

Article  CAS  PubMed  Google Scholar 

Dalrymple JM, Stamp LK, O’Donnell JL et al (2008) Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 58:3299–3308. https://doi.org/10.1002/art.24034

Article  CAS  PubMed  Google Scholar 

de Rotte MCFJ, Pluijm SMF, de Jong PHP et al (2018) Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis. PLoS ONE. https://doi.org/10.1371/journal.pone.0208534

Article  PubMed  PubMed Central  Google Scholar 

Halilova KI, Brown EE, Morgan SL et al (2012) Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand? Int J Rheumatol 2012:1–7. https://doi.org/10.1155/2012/978396

Article  CAS  Google Scholar 

Bulatović Ćalasan M, den Boer E, de Rotte MCFJ et al (2015) Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2013-203723

Article  Google Scholar 

De Rotte MCFJ, Den Boer E, De Jong PHP et al (2015) Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis. Ann Rheum Dis 74:408–414. https://doi.org/10.1136/annrheumdis-2013-203725

Article  CAS  PubMed  Google Scholar 

den Boer E, de Rotte MCJF, Pluijm SMF et al (2014) Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis. J Rheumatol. https://doi.org/10.3899/jrheum.131290

Article  Google Scholar 

van de Meeberg MM, Seinen ML, Fidder HH et al (2022) Subcutaneous administration, higher age and lower renal function are associated with erythrocyte methotrexate accumulation in Crohn’s disease: a cross-sectional study. BMC Gastroenterol 22:365. https://doi.org/10.1186/s12876-022-02439-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schimmelpennink MC, Vorselaars ADM, Veltkamp M, Keijsers RGM (2019) Quantification of pulmonary disease activity in sarcoidosis measured with 18F-FDG PET/CT: SUVmax versus total lung glycolysis. EJNMMI Res. https://doi.org/10.1186/s13550-019-0505-x

Article  PubMed  PubMed Central  Google Scholar 

Bakker AL, Grutters JC, Keijsers RG, Post MC (2017) Cardiac sarcoidosis: challenges in clinical practice. Curr Opin Pulm Med. https://doi.org/10.1097/MCP.0000000000000410

Article  PubMed  Google Scholar 

Adams H, Keijsers RG, Korenromp IHE, Grutters JC (2014) FDG PET for gauging of sarcoid disease activity. Semin Respir Crit Care Med. https://doi.org/10.1055/s-0034-1376866

Article  PubMed  Google Scholar 

Crouser ED, Maier LA, Wilson KC et al (2020) Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med 201:e26–e51. https://doi.org/10.1164/rccm.202002-0251ST

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takahashi C, Kaneko Y, Okano Y et al (2017) Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study. RMD Open 3:e000363. https://doi.org/10.1136/rmdopen-2016-000363

Article  PubMed  PubMed Central  Google Scholar 

den Boer E, Meesters RJW, van Zelst BD et al (2013) Measuring methotrexate polyglutamates in red blood cells: a new LC-MS/MS-based method. Anal Bioanal Chem 405:1673–1681. https://doi.org/10.1007/s00216-012-6581-7

Article  CAS  Google Scholar 

Jh O, Lodge MA, Wahl RL (2016) Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0. Radiology 280:576–584. https://doi.org/10.1148/radiol.2016142043

Article  Google Scholar 

Pinker K, Riedl C, Weber WA (2017) Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments. Eur J Nucl Med Mol Imaging 44:55–66. https://doi.org/10.1007/s00259-017-3687-3

Article  PubMed  PubMed Central  Google Scholar 

Fischer M, Siva S, Cook GK et al (2017) Methotrexate polyglutamate monitoring in patients with Crohn’s disease. Clin Pharmacol Drug Dev 6:240–245. https://doi.org/10.1002/cpdd.279

Article  CAS  PubMed  Google Scholar 

Cronstein BN, Aune TM (2020) Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol 16:145–154. https://doi.org/10.1038/s41584-020-0373-9

Article  CAS  PubMed  Google Scholar 

Stamp LK, O’Donnell JL, Chapman PT et al (2009) Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment. Arthritis Rheum 60:2248–2256. https://doi.org/10.1002/art.24653

Article  CAS  PubMed  Google Scholar 

Hebing RCF, Bartelink IH, Gosselt H et al (2023) Methotrexate polyglutamates exposure—response modeling in a large cohort of rheumatoid arthritis patients starting methotrexate. Clin Pharmacol Ther. https://doi.org/10.1002/cpt.2974

Article  PubMed  Google Scholar 

Zhao Z, Hua Z, Luo X et al (2022) Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother 150:113074. https://doi.org/10.1016/j.biopha.2022.113074

Article  CAS  PubMed  Google Scholar 

Pan S, Stamp LK, Duffull SB et al (2014) Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis. Clin Pharmacokinet. https://doi.org/10.1007/s40262-014-0179-5

Article  PubMed  Google Scholar 

Keijsers RGM, Grutters JC (2020) In which patients with sarcoidosis is FDG PET/CT indicated? J Clin Med. https://doi.org/10.3390/jcm9030890

Article  PubMed  PubMed Central  Google Scholar 

Markatis E, Afthinos A, Antonakis E, Papanikolaou IC (2020) Cardiac sarcoidosis: diagnosis and management. Rev Cardiovasc Med 21:321. https://doi.org/10.31083/j.rcm.2020.03.102

Article  PubMed  Google Scholar